Phase II and biomarker study of cabozantinib in metastatic triple-negative breast cancer patients

Sara M. Tolaney, David R. Ziehr, Hao Guo, Mei R. Ng, William T. Barry, Michaela J. Higgins, Steven J. Isakoff, Jane E. Brock, Elena V. Ivanova, Cloud P. Paweletz, Michelle K. Demeo, Nikhil H. Ramaiya, Beth A. Overmoyer, Rakesh K. Jain, Eric P. Winer, Dan G. Duda